Don’t Miss Cancer Programs Sessions at ACS Clinical Congress 2024

Register today for ACS Clinical Congress 2024, October 19-22 in San Francisco, California. Both in-person and virtual attendance options are available.

While at Clinical Congress, plan to attend these Cancer Programs sessions on Tuesday, October 22. Click on the title link to add the session to your interactive program planner.

PS303. Ductal Carcinomas in Situ (DCIS): Where Are We in 2024? Who Needs an Operation and Who Doesn’t?

8:00–9:30 am PT  

301–302 Level 3 South

Moderator: Catherine E. Pesce, MD, FACS
Co-Moderator: Rachel A. Greenup, MD, FACS

Panelists will discuss the rapidly changing management of Ductal Carcinoma In Situ (DCIS). The latest retrospective literature now suggests that some cases of DCIS may be treated with observation or with de-escalation and soon the results of the Comparison of Operative to Monitoring and Endocrine Therapy for low-risk ductal carcinoma In Situ (COMET) trial will determine if observation of DCIS is safe in certain patients.

PS313. ACS Operative Standards in Cancer Surgery: Recommendations for Resection of Primary Adrenal, Neuroendocrine, and Thyroid Malignancies

9:45–11:15 am PT

306–308 Level 3 South

Moderator: Barbra S. Miller, MD, FACS
Co-Moderator: Tracy S. Wang, MD, FACS

In this cutting-edge session, authors from the American Association of Endocrine Surgeons and the Society of Surgical Oncology who led the recently published ACS Operative Standards in Cancer Surgery sections on adrenal cancer, neuroendocrine cancers of the gastrointestinal tract and pancreas, and thyroid cancer will review in detail the technical aspects of resection of these malignancies. The session will include a video demonstration and question and answer period.

Click here to see a full list of Cancer Programs sessions at 2024 Clinical Congress.